Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
Hikal Limited, an Indian company established in 1988 with its headquarters in Navi Mumbai, manufactures and sells a variety of chemical products, including chemical intermediates, specialized chemicals, and active pharmaceutical ingredients (APIs). Its diverse client base includes companies in the pharmaceutical, animal healthcare, biotechnology, crop protection, and broader specialty chemicals sectors. The company operates through two main divisions: the Pharmaceuticals segment, which concentrates on the production of APIs, and the Crop Protection segment, responsible for herbicides and pesticides. Beyond its core manufacturing, Hikal also offers collaborative services such as contract research, custom synthesis, and bespoke manufacturing of intermediates and APIs. Additionally, they provide specialty biocides and antimicrobial agents that function as additives for a wide range of industries, including leather, paint coatings, paper, water treatment, personal care products, building materials, and textiles.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair val
Target Price
The average target price of HIKAL.NS is 320 and suggests 79% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc